BioByte 071: Unanswered questions, paused base-editing therapy, challenges with ASOs, GPT-4 for cell type annotation, the scientific journey behind Ozempic
BioByte 071: Unanswered questions, paused base-editing therapy, challenges with ASOs, GPT-4 for cell type annotation, the scientific journey behind Ozempic
Welcome to Decoding Bio, a writing collective focused on the latest scientific advancements, news, and people building at the intersection of tech x bio. Happy decoding! What we read Blogs Some questions about biotech that I find interesting [Alex Telford, March 2024]
Your 3rd thought is something I have been thinking about as well. Who and what will build dynamic systems models (PDEs, ODEs and SDEs) to attempt to simulate and possibly predict drug efficacy and toxicity. I have seen one company attempting this: Syntensor. Are there others?
Your 3rd thought is something I have been thinking about as well. Who and what will build dynamic systems models (PDEs, ODEs and SDEs) to attempt to simulate and possibly predict drug efficacy and toxicity. I have seen one company attempting this: Syntensor. Are there others?
Super interesting stuff!! Ty!!!